Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ST Pharm to construct second oligonucleotide facility in Korea

CPhIonlineDecember 03, 2021

Tag: ST Pharm , oligonucleotide , CDMO

PharmaSources Customer Service